Abstract
Locally advanced breast cancer (LABC) has a poor prognosis with a high risk of local recurrence and distant metastasis. Preoperative combined chemotherapy with or without granulocyte colony-stimulating factor (G-CSF) support does not improve the long-term survival rate. In our report, two patients with LABC received preoperative high-dose chemotherapy with peripheral blood stem cell support (HDC/PBSCs). Prior to high-dose chemotherapy with peripheral blood stem cell support, they both received induction chemotherapy of cyclophosphamide, epirubicin and 5-fluorouracil (FEC) for two cycles which resulted in a partial response. PBSC mobilization and collection were carried out following the second cycle of induction chemotherapy followed by G-CSF. High-dose cyclophosphamide (2500 mg/m2), carboplatin (600 mg/m2) and etoposide (600 mg/m2) were administered with PBSC support. A radical mastectomy was performed followed by adjuvant chemotherapy with FEC regimen for four cycles, followed by local irradiation, and endocrine therapy with tamoxifen. Both patients achieved a remarkable response in the primary lesion after HDC/PBSCs and tolerated the whole treatment well. Preoperative HDC/PBSCs as a new strategy in the treatment of LABC seems practical but it needs to be studied more deeply. Bone Marrow Transplantation (2001) 27, 345–346.
Similar content being viewed by others
References
Booser DJ, Hortobagyi GN . Treatment of locally advanced breast cancer Semin Oncol 1992 19: 278–285
Valero V . Future direction of neoadjuvant therapy for breast cancer Semin Oncol 1998 25: (Suppl. 3) 36–41
Rubens RD, Sexton S, Tong D et al. Combined chemotherapy and radiotherapy for locally advanced breast cancer Eur J Cancer 1980 16: 351–356
Mamounas EP . Overview of national surgical adjuvant breast project neoadjuvant chemotherapy studies Semin Oncol 1998 25: (Suppl. 3) 31–35
Fisher B, Brown A, Mamounas E et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18 J Clin Oncol 1997 15: 2483–2493
Stadtmauer EA, O'Neill A, Goldstein LJ et al. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group New Engl J Med 2000 342: 1069–1076
Antman KH . Critique of the high-dose chemotherapy studies in breast cancer: a positive look at the data J Clin Oncol 1999 17: (Suppl.) 30–34
Hortobagyi GN . High-dose chemotherapy for primary breast cancer: facts versus anecdotes J Clin Oncol 1999 17: (Suppl.) 25–29
Hortobagyi GN, Buzdar AU, Theriault RL . Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma J Natl Cancer Inst 2000 92: 225–233.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, X., Tang, J., Wu, J. et al. Preoperative high-dose chemotherapy with peripheral blood stem cell support as a primary management of locally advanced breast cancer. Bone Marrow Transplant 27, 345–346 (2001). https://doi.org/10.1038/sj.bmt.1702787
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702787
- Springer Nature Limited
Keywords
This article is cited by
-
Long-Term Treatment After Preoperative High-Dose Chemotherapy in a Lactating Breast Cancer Patient
Cell Biochemistry and Biophysics (2014)